EGFR and non-small cell lung carcinoma: Local therapy with continued EGFR inhibition has been shown to be effective for treating patients with oligoprogressive disease and associated with long PFS and OS.[22,23] As a new thermal ablation method, microwave ablation (MWA) for NSCLC is likely to be increasingly used, given its theoretical advantages over radiofrequency ablation (RFA) including a less severe heat sink effect and faster, greater heating.[24] We previously reported that advanced and medically inoperable stage I NSCLC could benefit from MWA therapy.